WJPR Citation New

  All Since 2011
 Citation  2903  2393
 h-index  27  24
 i10-index  68  60


Best Paper Awards

World Journal of Pharmaceutical Research (WJPR) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.
            Best Paper Award :
Dr. Muhammad Baqir MR Fakhrildin
Download Article: Click Here


Track Your Article



Harvinder Singh*, Kunda Jagadale, N.S. Mani, M.N. Karandikar and R.C. Nimbargi


Background: Ovarian neoplasms are now the leading cause of cancer related deaths in females and accounts for 3% of all neoplasms in females. Histomorphological study is the gold standard to assess the treatment modalities and prognosis of various tumours. This is a retrospective and prospective study which was carried over a period of 5 years from 2012 to 2016 which included 83 cases. Objectives: To document the spectrum of ovarian tumours by histopathological examination and their radiological and clinical correlation and age distribution. Methods: All the specimens were grossed according to standard grossing protocols. Formalin fixed paraffin embedded sections were stained with haematoxylin and eosin and examined microscopically. The medical record files of the patients were referred for clinical details and radiology reports. Results: Out of the 83 cases, 68 (82%) were benign, 15 (18%) were malignant. The most common tumours were surface epithelial tumours 52 (63%) followed by germ cell tumours 26 (31%) and sex cord-stromal tumours 4 (6%). Serous cystadenoma along with mature cystic teratoma being the most common benign tumours and serous cystadenocarcinoma, the most common malignant tumour. Most of the benign tumours were in 2nd and 3rd decade and malignant in 4th and 5th decade. Most common clinical presentations were mass per abdomen and ascites. Most of the radiology reports were suggestive of neoplasm Conclusion: Histopathological examination is the confirmatory modality for ovarian tumours. Most common tumours were surface epithelial tumours, both benign and malignant, seen in 3rd and 4th decade of life. Radiology has less specificity and is therefore inadequate for distinguishing between benign and malignant tumours.

Keywords: Ovarian tumours, benign, malignant, age groups.

[Full Text Article]

Call for Paper

World Journal of Pharmaceutical Research (WJPR)
Read More

Email & SMS Alert

World Journal of Pharmaceutical Research (WJPR)
Read More

Article Statistics

World Journal of Pharmaceutical Research (WJPR)
Read More

Online Submission

World Journal of Pharmaceutical Research (WJPR)
Read More